Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1497, Issue 2, 2000, Pages 215-226

  Wosikowski, Katja ^a   Silverman, Jeffrey A ^a   Bishop, Philippe ^a   Mendelsohn, John ^b   Bates, Susan E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANISOMYCIN; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; DNA-BINDING PROTEINS; DOXORUBICIN; DRUG RESISTANCE; EPIDERMAL GROWTH FACTOR; HUMANS; IMMUNOBLOTTING; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; PACLITAXEL; PHENOTYPE; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0034698123     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(00)00062-8     Document Type: Article

References (57)

1. Baral E., Auer G. Int. J. Radiat. Oncol. Biol. Physiol. 19:1990;963-965.
2. Baselga J., Norton L., Albanell J., Kim Y.M., Mendelsohn J. Cancer Res. 58:1998;2825-2831.
3. Baselga J., Norton L., Masui H., Pandiella A., Coplan K., Miller W.H. Jr., Mendelsohn J. J. Natl. Cancer Inst. 85:1993;1327-1333.
4. Bell G.I., Fong N.M., Stempien M.M., Wormsted M.A., Caput D., Ku L., Urdea M.S., Rall L.B., Sanchez-Prescador R. Nucleic Acids Res. 14:1986;8427-8446.
5. Benz C.C., Scott G.K., Sarup J.C., Johnson R.M., Tripathy D., Coronado E., Shepard H.M., Osborne C.K. Breast Cancer Res. Treat. 24:1992;85-95.
6. Brown R., Clugston C., Burns P., Edlin A., Vasey P., Vojtesek B., Kaye S.B. Int. J. Cancer. 55:1993;678-684.
7. Burgering B.M., Coffer P.J. Nature. 376:1995;599-602.
8. Ceccarelli C., Santini D., Chieco P., Taffurelli M., Gamberini M., Pileri S.A., Marrano D. J. Clin. Pathol. 51:1998;818-824.
9. G.M. Cooper, in: G.M. Cooper (Ed.), Oncogenes, 2nd ed., Jones and Bartlett, 1995, 279-306.
10. Coso O.A., Chiariello M., Yu J.-C., Teramoto H., Crespo P., Xu N., Miki T., Gutkind J.S. Cell. 81:1995;1137-1146.
11. Costa S., Stamm H., Almendral A., Ludwig H., Wyss R., Fabbro D., Ernst A., Takahashi A., Eppenberger U. Lancet. 2:1988;1258.
12. Darcy K.M., Wohlhueter A.L., Zangani D., Vaughan M.M., Russell J.A., Masso-Welch P.A., Varela L.M., Shoemaker S.F., Horn E., Lee P.P., Huang R.Y., Ip M.M. Eur. J. Cell Biol. 78:1999;511-523.
13. Datta S.R., Brunet A., Greenberg M.E. Genes Dev. 13:1999;2905-2927.
14. Derijard B., Hibi M., Wu H., Barrett C., Su B., Deng T., Karin M., Davis R.J. Cell. 76:1994;1025-1037.
15. Dickstein B., Valverius E.M., Wosikowski K., Saceda M., Pearson J.W., Martin M.B., Bates S.E. J. Cell Physiol. 157:1993;110-118.
16. Dickstein B., Wosikowski K., Bates S.E. Mol. Cell Endocrinol. 110:1995;205-211.
17. Drewinko B., Pathcen M., Yang L., Barlogie B. Cancer Res. 41:1981;2328-2333.
18. Fan Z., Baselga J., Masui H., Mendelsohn J. Cancer Res. 53:1993;4637-4642.
19. Filmus F., Pollak M.N., Cailleau R., Buick R.N. Biochem. Biophys. Res. Commun. 128:1985;898-905.
20. Gill G.N., Kawamot T., Cochet C., Le A., Sato J.D., Masui H., McLeod C., Mendelsohn J. J. Biol. Chem. 259:1984;7755-7760.
21. Gusterson B.A., Gelber R.D., Goldhirsch A. J. Clin. Oncol. 10:1992;1049-1056.
22. Ioachim E., Kamina S., Athanassiadou S., Agnantis N.J. Anticancer Res. 16:1996;3141-3147.
23. Kacinski B.M., Yee L.D., Carter D., Li D., Kuo M.T. Cancer Commun. 1:1989;1-6.
24. Kandel E.S., Hay N. Exp. Cell Res. 253:1999;210-229.
25. Kang Y.K., Zhan Z., Regis J., Robey R., Meadows B., Dickstein B., Lee J.S., Otsuki T., Stetler-Stevenson M.A., Jaffe E.S., Solomon D., Wilson W.H., Fojo A., Bates S.E. Blood. 86:1995;1515-1524.
26. Kroning R., Jones J.A., Hom D.K., Chuang C.C., Sanga R., Los G., Howell S.B., Christen R.D. Br. J. Cancer. 72:1995;615-619.
27. Lee S.A., Karaszkiewicz J.W., Anderson W.B. Cancer Res. 52:1992;3750-3759.
28. Lee W.-P. Cancer Lett. 73:1993;105-111.
29. Lei W., Mayotte J.E., Levitt M.L. Anticancer Res. 19:1999;221-228.
30. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., Lowe S.W. Genes Dev. 12:1998;3008-3019.
31. Luetteke N.C., Qiu T.H., Fenton S.E., Troyer K.L., Riedel R.F., Chang A., Lee D.C. Development. 126:1999;2739-2750.
32. Meyers M.B., Shen W.P.V., Spengler B.A., Ciccarone V., O'Brien J.P., Donner D.B., Furth M.E., Biedler J.L. J. Cell Biochem. 38:1988;87-97.
33. Minderman H., Linssen P.C., Wessels J.M., Haanen C. Exp. Hematol. 19:1991;110-114.
34. Miyake K., Mickley L., Litman T., Zhan Z., Robey R., Cristensen B., Brangi M., Greenberger L., Dean M., Fojo T., Bates S.E. Cancer Res. 59:1999;8-13.
35. Mueller H., Loop P., Liu R., Wosikowski K., Kueng W., Eppenberger U. Eur. J. Biochem. 221:1994;631-637.
36. Muss H.B., Thor A.D., Berry D.A., Kute T., Liu E.T., Koerner F., Cirrincione C.T., Budman D.R., Wood W.C., Barcos M., Henderson I.C. N. Engl. J. Med. 330:1994;1260-1266.
37. Nicholson S., Sainsbury J.R.C., Halcrow P., Chambers P., Farndon J.R., Harris A.L. Lancet. 1:1989;182-185.
38. Normanno N., Ciardiello F., Brandt R., Salomon D.S. Breast Cancer Res. Treat. 29:1994;11-27.
39. Oehler M.K., Rehn M., Kristen P., Sutterlin M., Caffier H. Anticancer Res. 17:1997;3137-3140.
40. Pegram M.D., Lipton A., Hayes D.F., Weber B.L., Baselga J.M., Tripathy D., Baly D., Baughman S.A., Twaddell T., Glaspy J.A., Slamon D.J. J. Clin. Oncol. 16:1998;2659-2671.
41. Pietras R.J., Fendly B.M., Chazin V.R., Pegram M.D., Howell S.B., Slamon D.J. Oncogene. 9:1994;1829-1838.
42. Reeve J.G., Rabbitts P.H., Twentyman P.R. Br. J. Cancer. 61:1990;851-855.
43. Rosfjord E.C., Dickson R.B. J. Mammary Gland Biol. Neoplasia. 4:1999;229-237.
44. Saceda, M., Knabbe, C., Dickson, R.B., Lippman, M.E., Bronzert, D., Lindsey, R.K., Gottardis, M.M. and Martin, M.B. (1991) J. Biol. Chem., 17809-17814.
45. Sainsbury J.R.C., Farndon J.R., Needham G.K., Malcolm A.J., Harris A.L. Lancet. 1:1987;1398-1402.
46. Sartor O., Sameshima J.H., Robbins K.C. J. Biol. Chem. 266:1991;6462-6466.
47. Seger R., Krebs E.G. FASEB J. 9:1995;726-735.
48. Sheffield L.G. J. Endocrinol. 159:1998;111-116.
49. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1107-1112.
50. Sommers C.L., Heckford S.E., Skerker J.M., Worland P., Torri J.A., Thompson E.W., Byers S.W., Gelmann E.P. Cancer Res. 52:1992;5190-5197.
51. Takano H., Kohno K., Shiraishi N., Sato S.I., Asoh K.I., Yakushinji M., Ono M., Kuwano M. Jpn. J. Cancer Res. 80:1989;373-379.
52. Thor A.D., Berry D.A., Budman D.R., Muss H.B., Kute T., Henderson I.C., Barcos M., Cirrincione C., Edgerton S., Allred C., Norton L., Liu E.T. J. Natl. Cancer Inst. 90:1998;1346-1360.
53. Tibbles L.A., Woodgett J.R. Cell Mol. Life Sci. 55:1999;1230-1254.
54. Treisman R. Curr. Opin. Cell Biol. 8:1996;205-215.
55. Wosikowski K., Schuurhuis D., Kops G.J., Saceda M., Bates S.E. Clin. Cancer Res. 3:1997;2405-2414.
56. Yu D., Liu B., Tan M., Li J., Wang S.S., Hung M.C. Oncogene. 13:1996;1359-1365.
57. Zimmermann S., Moelling K. Science. 286:1999;1741-1744.